Article info

Download PDFPDF
Increased risk of multiple myeloma in primary Sjögren’s syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies

Authors

  1. Correspondence to Professor Marie Wahren-Herlenius, Department of Medicine, Karolinska Institutet, Stockholm SE-171 76, Sweden; marie.wahren{at}ki.se
View Full Text

Citation

Mofors J, Björk A, Smedby KE, et al
Increased risk of multiple myeloma in primary Sjögren’s syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies

Publication history

  • Received September 8, 2019
  • Revised October 9, 2019
  • Accepted October 24, 2019
  • First published November 6, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.